Glory Health Industry Limited
HKEX:2329.HK
0.1 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,049.418 | 1,456.867 | 958.404 | 2,946.268 | 3,323.848 | 6,574.553 | 2,446.531 | 3,322.365 | 4,318.264 | 3,774.912 | 4,374.097 | 2,238.388 | 4,605.525 | 2,181.89 | 4,378.96 | 3,655.621 | 3,924.64 | 2,589.664 | 3,016.092 | 2,262.454 | 3,834.61 | 3,000.748 | 1,708.84 |
| Cost of Revenue
| 1,279.848 | 1,276.717 | 668.57 | 3,122.585 | 3,124.484 | 5,526.682 | 2,326.308 | 2,462.267 | 3,254.209 | 2,700.246 | 2,538.855 | 1,474.428 | 2,432.357 | 1,186.186 | 2,761.572 | 2,154.919 | 2,573.856 | 1,261.629 | 1,542.564 | 1,330.804 | 2,406.567 | 724.117 | 782.671 |
| Gross Profit
| -230.43 | 180.15 | 289.834 | -176.317 | 199.364 | 1,047.871 | 120.223 | 860.098 | 1,064.055 | 1,074.666 | 1,835.242 | 763.96 | 2,173.168 | 995.704 | 1,617.388 | 1,500.702 | 1,350.784 | 1,328.035 | 1,473.528 | 931.65 | 1,428.043 | 2,276.631 | 926.169 |
| Gross Profit Ratio
| -0.22 | 0.124 | 0.302 | -0.06 | 0.06 | 0.159 | 0.049 | 0.259 | 0.246 | 0.285 | 0.42 | 0.341 | 0.472 | 0.456 | 0.369 | 0.411 | 0.344 | 0.513 | 0.489 | 0.412 | 0.372 | 0.759 | 0.542 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 155.311 | 191.043 | 198.223 | 166.035 | 213.454 | 190.15 | 223.849 | 243.894 | 288.072 | 268.73 | 295.01 | 206.77 | 176.262 | 178.387 | 180.877 | 142.217 | 199.642 | 158.96 | 136.522 | 135.69 | 124.409 | 117.409 | 60.567 |
| Selling & Marketing Expenses
| 25.318 | 58.198 | 29.267 | 67.043 | 163.716 | 100.204 | 145.137 | 128.337 | 141.942 | 164.006 | 120.071 | 86.728 | 91.263 | 103.652 | 130.59 | 130.227 | 119.528 | 126.628 | 98.859 | 83.587 | 111.713 | 72.832 | 46.136 |
| SG&A
| 168.286 | 266.003 | 226.32 | 302.332 | 458.17 | 293.048 | 363.808 | 377.409 | 430.476 | 432.736 | 421.116 | 293.498 | 273.56 | 282.039 | 317.502 | 272.444 | 319.277 | 285.588 | 235.488 | 219.277 | 236.209 | 190.605 | 106.704 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105.964 | -101.192 | -101.192 |
| Operating Expenses
| 180.25 | 432.88 | 298.725 | 527.813 | 493.244 | 202.648 | 42.429 | 141.676 | 8.853 | 123.799 | 377.523 | 255.762 | 334.937 | 182.042 | 42.484 | 190.089 | 163.749 | 319.285 | 128.415 | 239.697 | 191.339 | 523.887 | 5.512 |
| Operating Income
| -398.716 | -85.853 | 63.514 | -478.649 | -258.806 | 754.823 | -243.585 | 482.689 | 633.579 | 641.93 | 1,414.126 | 470.462 | 1,899.608 | 713.665 | 1,299.886 | 1,228.258 | 1,031.507 | 1,042.447 | 1,238.04 | 712.373 | 1,191.834 | 2,086.026 | 887.998 |
| Operating Income Ratio
| -0.38 | -0.059 | 0.066 | -0.162 | -0.078 | 0.115 | -0.1 | 0.145 | 0.147 | 0.17 | 0.323 | 0.21 | 0.412 | 0.327 | 0.297 | 0.336 | 0.263 | 0.403 | 0.41 | 0.315 | 0.311 | 0.695 | 0.52 |
| Total Other Income Expenses Net
| 5.362 | -199.413 | -299.133 | -376.076 | 310.998 | 69.852 | 195.251 | 82.366 | 416.09 | 354.564 | 372.446 | 440.434 | 569.742 | 384.118 | 315.53 | 386.753 | 102.321 | 523.323 | 271.49 | -162.894 | -30.844 | 608.768 | 75.948 |
| Income Before Tax
| -393.354 | -285.266 | -235.619 | -854.725 | 52.192 | 824.675 | -48.334 | 565.055 | 1,049.669 | 996.494 | 1,786.572 | 910.896 | 2,469.35 | 1,097.783 | 1,615.416 | 1,615.011 | 1,133.828 | 1,565.77 | 1,509.53 | 549.479 | 1,160.99 | 2,694.794 | 963.946 |
| Income Before Tax Ratio
| -0.375 | -0.196 | -0.246 | -0.29 | 0.016 | 0.125 | -0.02 | 0.17 | 0.243 | 0.264 | 0.408 | 0.407 | 0.536 | 0.503 | 0.369 | 0.442 | 0.289 | 0.605 | 0.5 | 0.243 | 0.303 | 0.898 | 0.564 |
| Income Tax Expense
| 69.668 | 15.449 | 18.15 | 76.901 | 78.24 | 454.112 | 99.044 | 284.032 | 399.903 | 426.647 | 775.56 | 352.677 | 1,060.289 | 467.333 | 660.141 | 614.598 | 519.081 | 597.028 | 587.869 | 264.851 | 388.807 | 696.788 | 271.399 |
| Net Income
| -297.097 | -266.874 | -230.298 | -682.484 | -38.213 | 266.546 | 27.434 | 71.306 | 431.188 | 428.576 | 598.338 | 410.446 | 1,251.548 | 498.293 | 699.342 | 863.614 | 487.439 | 773.111 | 727.037 | 223.617 | 617.425 | 1,616.387 | 692.547 |
| Net Income Ratio
| -0.283 | -0.183 | -0.24 | -0.232 | -0.011 | 0.041 | 0.011 | 0.021 | 0.1 | 0.114 | 0.137 | 0.183 | 0.272 | 0.228 | 0.16 | 0.236 | 0.124 | 0.299 | 0.241 | 0.099 | 0.161 | 0.539 | 0.405 |
| EPS
| -0.07 | -0.06 | -0.056 | -0.15 | -0.009 | 0.06 | 0.006 | 0.016 | 0.097 | 0.096 | 0.13 | 0.092 | 0.28 | 0.11 | 0.16 | 0.19 | 0.11 | 0.17 | 0.17 | 0.06 | 0.15 | 0.36 | 0.16 |
| EPS Diluted
| -0.067 | -0.06 | -0.052 | -0.15 | -0.009 | 0.06 | 0.006 | 0.016 | 0.097 | 0.096 | 0.13 | 0.092 | 0.28 | 0.11 | 0.16 | 0.19 | 0.11 | 0.17 | 0.17 | 0.06 | 0.15 | 0.36 | 0.16 |
| EBITDA
| -357.639 | -50.355 | 121.876 | -447.807 | -203.502 | 785.048 | -201.333 | 521.121 | 671.079 | 680.413 | 1,449.411 | 507.457 | 1,915.859 | 729.129 | 1,318.2 | 1,241.836 | 1,045.235 | 1,055.123 | 1,248.856 | 722.496 | 1,204.08 | 2,097.512 | 894.076 |
| EBITDA Ratio
| -0.341 | -0.035 | 0.127 | -0.152 | -0.061 | 0.119 | -0.082 | 0.157 | 0.155 | 0.18 | 0.331 | 0.227 | 0.416 | 0.334 | 0.301 | 0.34 | 0.266 | 0.407 | 0.414 | 0.319 | 0.314 | 0.699 | 0.523 |